Shu-shen Zheng - Infectious Diseases

Author Information

Shusen Zheng is a distinguished expert in the field of hepatobiliary and pancreatic surgery, with a notable focus on liver transplantation and related research. He is affiliated with the Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases and the Key Laboratory of Combined Multi-organ Transplantation at the Ministry of Public Health, based at the Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University in Hangzhou, China. This affiliation underscores his pivotal role in advancing clinical practices and research in liver-related diseases and transplantation.

Research Contributions

Shusen Zheng has significantly contributed to the field of liver transplantation and hepatocellular carcinoma. His research spans various aspects of liver diseases, including the application of multiomics data in clinical liver transplantation, personalized drug screening, anti-tumor immunity, and the prognostic modeling of hepatocellular carcinoma. Notably, his work often incorporates innovative approaches such as the use of multiomics data and the exploration of immune mechanisms in liver cancer models, aiming to enhance outcomes and understand the recurrence of liver diseases post-transplantation.

Aliases

Shusen Zheng is also known by the name variations Shu-sen Zheng and Shu-shen Zheng. These aliases might appear in different publications or databases.

Publication and Citation Metrics

Citation Count	11,224
H-index	56
Paper Count	514

Publications:

Recent Progress and Future Direction for the Application of Multiomics Data in Clinical Liver Transplantation

DOI: 10.14218/jcth.2021.00219

Year: 2022

Culture of patient-derived multicellular clusters in suspended hydrogel capsules for pre-clinical personalized drug screening

DOI: 10.1016/j.bioactmat.2022.03.020

Year: 2022

Blocking CD47 promotes anti-tumor immunity through CD103+ dendritic cell-NK cell axis in murine hepatocellular carcinoma model.

DOI: 10.1016/j.jhep.2022.03.011

Year: 2022

Liver transplantation for Hepatocellular Carcinoma: A prognostic model incorporating pretransplant inflammatory cytokines.

DOI: 10.1016/j.cyto.2022.155847

Year: 2022

A model integrated fibrinogen and D-dimer for prediction of hepatocellular carcinoma recurrence following liver transplantation: a multicentre study.

DOI:

Year: 2022

Utilization of HBV surface antigen positive grafts in liver transplantation: A matched study based on a national registry cohort.

DOI: 10.1111/jgh.15821

Year: 2022

Sox15 Methylation Inhibits Cell Proliferation Through Wnt Signaling in Hepatocellular Carcinoma

DOI: 10.3389/fonc.2022.842312

Year: 2022

Impact of hepatitis-B-surface-antigen-positive grafts on liver transplantation in patients with benign and malignant liver disease.

DOI: 10.1002/jmv.27703

Year: 2022

Polyploidy Spectrum Correlates with Immunophenotype and Shapes Hepatocellular Carcinoma Recurrence Following Liver Transplantation.

DOI: 10.2147/jir.s345681

Year: 2022

A pan-cancer analysis of the oncogenic role of Holliday junction recognition protein in human tumors

DOI: 10.1515/med-2022-0423

Year: 2022

How is Inherited Immunity Studied?

Why is Surveillance Important?

What are the Complications of Measles?

What are the Achievements of the RBM Partnership?

What is Viral Mutation and Why is it Important?

How Do Infectious Diseases Affect Lipid Metabolism?

What is Glycolysis?

Why is Hygiene Important in Infectious Diseases?

How Do APCs Capture and Process Antigens?

What are Some Natural Alternatives to Chemical Insect Repellents?

Partnered Content Networks

Relevant Topics